Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Tangible Net Worth Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Tangible Net Worth Ratio of 98.3% as of March 2026. This metric is calculated by deducting intangible assets (CN¥263.85 Million) from net assets (CN¥15.76 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of Zhangzhou Pientzehuang Pharmaceutical Co for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Tangible Net Worth Ratio (2000–2025)
This chart shows how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 26 annual periods from 2000 to 2025. As of March 2026, the ratio stands at 98.3%, reflecting net assets of CN¥15.76 Billion with intangible assets of CN¥263.85 Million CNY. Also explore Zhangzhou Pientzehuang Pharmaceutical Co (600436) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2000–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2000 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Zhangzhou Pientzehuang Pharmaceutical Co worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.2% | CN¥15.09 Billion | CN¥267.49 Million | CN¥17.56 Billion | ▲ +0.1 pp |
| 2024 | 98.2% | CN¥14.84 Billion | CN¥273.10 Million | CN¥17.54 Billion | ▲ +0.3 pp |
| 2023 | 97.9% | CN¥13.92 Billion | CN¥291.09 Million | CN¥17.08 Billion | ▲ +0.6 pp |
| 2022 | 97.3% | CN¥11.82 Billion | CN¥319.37 Million | CN¥14.60 Billion | ▼ -0.5 pp |
| 2021 | 97.8% | CN¥10.14 Billion | CN¥220.96 Million | CN¥12.50 Billion | ▲ +1.0 pp |
| 2020 | 96.9% | CN¥8.26 Billion | CN¥259.38 Million | CN¥10.21 Billion | ▼ -0.9 pp |
| 2019 | 97.8% | CN¥6.97 Billion | CN¥155.66 Million | CN¥8.81 Billion | ▲ +0.0 pp |
| 2018 | 97.7% | CN¥5.31 Billion | CN¥121.06 Million | CN¥6.66 Billion | ▲ +1.6 pp |
| 2017 | 96.1% | CN¥4.43 Billion | CN¥173.93 Million | CN¥5.65 Billion | ▲ +3.9 pp |
| 2016 | 92.2% | CN¥3.75 Billion | CN¥293.44 Million | CN¥5.04 Billion | ▼ -2.8 pp |
| 2015 | 95.0% | CN¥3.30 Billion | CN¥164.47 Million | CN¥4.05 Billion | ▲ +0.6 pp |
| 2014 | 94.4% | CN¥2.99 Billion | CN¥166.76 Million | CN¥3.65 Billion | ▼ -0.7 pp |
| 2013 | 95.1% | CN¥2.59 Billion | CN¥125.75 Million | CN¥3.26 Billion | ▲ +1.1 pp |
| 2012 | 94.0% | CN¥1.56 Billion | CN¥92.94 Million | CN¥2.23 Billion | ▼ -1.0 pp |
| 2011 | 95.1% | CN¥1.19 Billion | CN¥58.76 Million | CN¥1.57 Billion | ▲ +0.9 pp |
| 2010 | 94.2% | CN¥1.08 Billion | CN¥63.25 Million | CN¥1.45 Billion | ▼ -0.2 pp |
| 2009 | 94.4% | CN¥857.19 Million | CN¥48.02 Million | CN¥1.28 Billion | ▲ +0.2 pp |
| 2008 | 94.2% | CN¥752.09 Million | CN¥43.94 Million | CN¥1.07 Billion | ▼ -0.7 pp |
| 2007 | 94.9% | CN¥758.85 Million | CN¥39.05 Million | CN¥970.88 Million | ▼ -2.4 pp |
| 2006 | 97.3% | CN¥621.09 Million | CN¥16.83 Million | CN¥730.62 Million | ▲ +0.1 pp |
| 2005 | 97.2% | CN¥608.07 Million | CN¥16.97 Million | CN¥693.63 Million | ▼ -2.8 pp |
| 2004 | 100.0% | CN¥539.08 Million | CN¥199.70K | CN¥558.77 Million | ▲ +0.0 pp |
| 2003 | 100.0% | CN¥553.59 Million | CN¥225.20K | CN¥594.99 Million | ▲ +0.1 pp |
| 2002 | 99.8% | CN¥154.81 Million | CN¥250.69K | CN¥325.79 Million | ▼ -0.2 pp |
| 2001 | 100.0% | CN¥146.02 Million | CN¥0.00 | CN¥270.36 Million | ▲ +0.0 pp |
| 2000 | 100.0% | CN¥141.35 Million | CN¥0.00 | CN¥258.68 Million | — |